ProStrakan announces positive results from Fortigel study
ProStrakan Group Plc, the international pharmaceutical company, announced positive results from the pivotal US clinical program on Fortigel, its testosterone replacement treatment.
United Drug posts strong first half profits
The Irish healthcare services company United Drug yesterday reported a period of double digit profit, earnings and dividend growth for the first half of 2008.
S&N to take £50 million hit on lost sales; launches investigation
Smith & Nephew, the FTSE 100 medical group said Thursday that “unacceptable” sales practices in a business it bought last year will cost it more than $100 million (£50 million) in lost sales this year.
New GSK boss Witty reshuffles corporate management
GlaxoSmithKline Plc’s incoming chief executive Andrew Witty announces changes to the group’s corporate management team.
Pharmaceutical companies hint at tax move to Ireland
AstraZeneca, the Anglo-Swedish pharmaceutical group, yesterday refused to rule out moving their headquarters to Ireland to reduce the impact of taxes in the UK.
Shire Plc announces first quarter sales growth
Shire Pharmaceuticals Plc has reported a first quarter revenue increase of 33 percent to $702 million, with new product launches contributing to the strong growth.